Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.

× No keyword cloud information.

7 in total

1. Intravesical oxybutynin protects the vesical wall against functional and smooth muscle changes in rabbits with detrusor overactivity.

Authors: Armando Polido Júnior; José Mateus Costa; Tânia Munhoz; Francisco José Sampaio; Luiz Eduardo Macedo Cardoso; João Luiz Amaro
Journal: Int Urogynecol J Date: 2010-07-14 Impact factor: 2.894

2. A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive bladder.

Authors: Michael J Kennelly
Journal: Rev Urol Date: 2010

3. Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study.

Authors: David Dothan; Galiya Raisin; Nadav Malchi; Avi Gordon; Dan Touitou; Boris Chertin
Journal: Int Urol Nephrol Date: 2022-07-03 Impact factor: 2.266

4. Influence of urothelial or suburothelial cholinergic receptors on bladder reflexes in chronic spinal cord injured cats.

Authors: Timothy D Ungerer; Kyoungeun A Kim; Stephanie L Daugherty; James R Roppolo; Changfeng Tai; William C de Groat
Journal: Exp Neurol Date: 2016-07-14 Impact factor: 5.330

Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.

1. Intravesical oxybutynin protects the vesical wall against functional and smooth muscle changes in rabbits with detrusor overactivity.

2. A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive bladder.

3. Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study.

4. Influence of urothelial or suburothelial cholinergic receptors on bladder reflexes in chronic spinal cord injured cats.

5. The spectrum of urological disease in patients with spina bifida.

Review 6. Role of fesoterodine in the treatment of overactive bladder.

Review 7. Implantable Devices for Sustained, Intravesical Drug Delivery.